Experience convenient blood cancer treatment close to home. Find out how this unique partnership brings autologous stem cell ...

The global Phase III VANCE trial of the autologous EBV-targeted T-cell therapy was the largest trial of a solid tumor cell ...

As a result of the follow-up observation of patients who received BMAC intra-articular injection procedures by Himchan ...

The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...

The following is a summary of “Autologous Peripheral Blood-Derived Orthobiologics for the Management of Shoulder Disorders: A ...

Anocca has submitted its first clinical trial application (CTA) to the European Medicines Agency (EMA) for conducting the ...

Despite challenges such as high attrition rates and adverse events, the trial highlights the value of established therapies ...

ADIA Med will particularly explore the use of Mesenchymal Stem Cells (MSCs), especially from Umbilical Cord sources, for ...

Medigene will slim its headcount by 40% and pause plans to get its first asset into the clinic in order to channel cash to ...

The Swedish firm plans to expand the VIDAR-1 umbrella trial to study additional KRAS-targeting product candidates in the future.

Planegg/Martinsried, November 26, 2024.Medigene AG (Medigene, FSE: MDG1, Prime Standard), an oncology platform company focused on the research ...

SCG has revealed late-breaking data outcomes from the Phase I clinical trial of autologous hepatitis B virus (HBV)-specific T ...